ImmunityBio converts from Immunomedics | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
ImmunityBio converts from Immunomedics

An SI Board Since February 2023

Posts	SubjectMarks	Bans	Symbol
1518	51	0	IBRX

Emcee: TinfoilHat	Type: Moderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
854	From ST board this morning huggenberg5:00 AM $IBRX The full report on five pa	Redman1234	4	1/29/2025
853	This board can continue to knock "quacks" like RFK but the medical est	sukit	3	1/28/2025
852	What would you rather have? The chance of heart failure or the surety of death	waitwatchwander	1	1/28/2025
851	Price doesn't really matter much. I have a small position. Larger positions	Stanley Lake 92	-	1/28/2025
850	No, man. That wasn't a one off thing. PSS communicates on X continually. I&	Stanley Lake 92	-	1/28/2025
849	I realize this group doesn’t have the type of censorship as the IMMU group but f	dorightbythem	-	1/27/2025
848	Why, and at what price?	bobbseytwins2001	-	1/27/2025
847	Slay News. Just the source I'd think of posting. x.com Looking for the exi	Stanley Lake 92	2	1/27/2025
846	Frustrating but I have to think that the market saw no real chance that the appl	jargonweary	1	1/27/2025
845	Unfortunately, same old story good news no volume and share price increase.	dorightbythem	-	1/27/2025
844	Here is Chat-GPTs thinking about the significance of todays PR Summary of t	End2War	4	1/27/2025
843	ImmunityBio announces european medicines agency acceptance of marketing authoriz	TripleE3	2	1/27/2025
842	Thanks for the well researched response.	publicsceenname	2	1/21/2025
841	Not really a threat (see below for clarity on logic), in my experience oncologis	TinfoilHat	4	1/21/2025
840	How does JNJ's bladder cancer drug progress not threaten IBRX? innovativem	publicsceenname	-	1/21/2025
839	This may be the first usage of “silly” in this manner on the IMMU board: Messag	Olecranon	4	1/18/2025
838	Please keep SAVA comments to the other boards. Bad Karma. Assuming you must own	galt	1	1/17/2025
837	Point taken. Here's another (very old) quote about Wall Street...."Beli	mannamal	1	1/17/2025
836	---------- If I remember correctly it's..."the number's could get s	erickerickson	-	1/17/2025
835	I've got to say the JPM presentation was certainly audacious. Thinking of th	mannamal	1	1/17/2025
834	Another humdinger of a post from huggenberg. All I can say is wow! $IBRX Reve	Redman1234	2	1/16/2025
833	Don’t forget ASCO GI is next week. What tidbits on Colon and Prostate trials mig	Redman1234	-	1/16/2025
832	Great find. Keep in mind Pharma companies always insert a pre-specified early lo	TinfoilHat	8	1/16/2025
831	From huggenberg ST board. I also as mentioned before expect UK approval with ei	Redman1234	4	1/16/2025
830	CULVER CITY, Calif.--(BUSINESS WIRE)--Jan. 15, 2025-- ImmunityBio, Inc. ( NASDAQ	zagnut1	5	1/15/2025

Go to reply# or date (mm/dd/yy):